{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:06:02Z","timestamp":1788001562047,"version":"build-2784847793"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10555-020-09847-0","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T03:02:43Z","timestamp":1578884563000},"page":"3-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Neurological complications of pediatric cancer"],"prefix":"10.1007","volume":"39","author":[{"given":"Caren","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"issue":"12","key":"9847_CR1","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00431-002-1088-4","volume":"161","author":"M Dobrovoljac","year":"2002","unstructured":"Dobrovoljac, M., Hengartner, H., Boltshauser, E., & Grotzer, M. (2002). Delay in the diagnosis of paediatric brain tumours. Eur J Pediatr, 161(12), 663\u2013667. https:\/\/doi.org\/10.1007\/s00431-002-1088-4.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"9847_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0883073807308692","volume":"23","author":"BC Reulecke","year":"2008","unstructured":"Reulecke, B. C., Erker, C. G., Fiedler, B. J., Niederstadt, T.-U., & Kurlemann, G. (2008). Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol, 23(2), 178\u2013183. https:\/\/doi.org\/10.1177\/0883073807308692.","journal-title":"J Child Neurol"},{"issue":"11","key":"9847_CR3","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1177\/0883073809342491","volume":"24","author":"NJ Ullrich","year":"2009","unstructured":"Ullrich, N. J. (2009). Neurologic sequelae of brain tumors in children. J Child Neurol, 24(11), 1446\u20131454. https:\/\/doi.org\/10.1177\/0883073809342491.","journal-title":"J Child Neurol"},{"issue":"2","key":"9847_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1212\/01.CON.0000464176.96311.d1","volume":"21","author":"EM Wells","year":"2015","unstructured":"Wells, E. M., & Packer, R. J. (2015). Pediatric brain tumors. CONTINUUM: Lifelong Learning in Neurology, 21(2), 373\u2013396. https:\/\/doi.org\/10.1212\/01.CON.0000464176.96311.d1.","journal-title":"CONTINUUM: Lifelong Learning in Neurology"},{"issue":"8","key":"9847_CR5","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00381-016-3145-8","volume":"32","author":"F Malbari","year":"2016","unstructured":"Malbari, F., Gershon, T. R., Garvin, J. H., Allen, J. C., Khakoo, Y., Levy, A. S., & Dunkel, I. J. (2016). Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series. Childs Nerv Syst, 32(8), 1359\u20131362. https:\/\/doi.org\/10.1007\/s00381-016-3145-8.","journal-title":"Childs Nerv Syst"},{"key":"9847_CR6","doi-asserted-by":"publisher","unstructured":"Taylor M, Couto-Silva, A-C, Adan L, Trivin C, Sainte-Rose C, Zerah M, \u2026 Brauner R (2012). Hypothalamic-pituitary lesions in pediatric patients: endocrine symptoms often precede neuro-ophthalmic presenting symptoms. J Pediatr, 161(5), 855\u201363. doi:https:\/\/doi.org\/10.1016\/j.jpeds.2012.05.014.","DOI":"10.1016\/j.jpeds.2012.05.014"},{"issue":"3","key":"9847_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/BPO.0b013e318247195a","volume":"32","author":"J Pretell-Mazzini","year":"2012","unstructured":"Pretell-Mazzini, J., Chikwava, K. R., & Dormans, J. P. (2012). Low back pain in a child associated with acute onset cauda equina syndrome: a rare presentation of an aggressive vertebral hemangioma: a case report. J Pediatr Orthop, 32(3), 271\u2013276. https:\/\/doi.org\/10.1097\/BPO.0b013e318247195a.","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"9847_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1096-911X(199902)32:2<102::AID-MPO6>3.0.CO;2-Y","volume":"32","author":"J Mora","year":"1999","unstructured":"Mora, J., & Wollner, N. (1999). Primary epidural non-Hodgkin lymphoma: spinal cord compression syndrome as the initial form of presentation in childhood non-Hodgkin lymphoma. Med Pediatr Oncol, 32(2), 102\u2013105. https:\/\/doi.org\/10.1002\/(SICI)1096-911X(199902)32:2<102::AID-MPO6>3.0.CO;2-Y.","journal-title":"Med Pediatr Oncol"},{"issue":"5","key":"9847_CR9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/foc.2006.21.5.8","volume":"21","author":"AN Da Silva","year":"2006","unstructured":"Da Silva, A. N., Lopes, M. B., & Schiff, D. (2006). Rare pathological variants and presentations of primary central nervous system lymphomas. Neurosurg Focus, 21(5), E1\u2013E7. https:\/\/doi.org\/10.3171\/foc.2006.21.5.8.","journal-title":"Neurosurg Focus"},{"issue":"sup1","key":"9847_CR10","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1080\/10790268.2007.11753963","volume":"30","author":"RE Wilson","year":"2007","unstructured":"Wilson, R. E., Oleszek, J. L., & Clayton, G. H. (2007). Pediatric spinal cord tumors and masses. J Spinal Cord Med, 30(sup1), S15\u2013S20. https:\/\/doi.org\/10.1080\/10790268.2007.11753963.","journal-title":"J Spinal Cord Med"},{"issue":"4","key":"9847_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00247-019-04371-y","volume":"49","author":"GM Ma","year":"2019","unstructured":"Ma, G. M., Chow, J. S., & Taylor, G. A. (2019). Review of paraneoplastic syndromes in children. Pediatr Radiol, 49(4), 534\u2013550. https:\/\/doi.org\/10.1007\/s00247-019-04371-y.","journal-title":"Pediatr Radiol"},{"issue":"5","key":"9847_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pediatrneurol.2012.02.025","volume":"46","author":"DM Nikolic","year":"2012","unstructured":"Nikolic, D. M., Nikolic, A. V., Lavrnic, D. V., Medjo, B. P., & Ivanovski, P. I. (2012). Childhood-onset myasthenia gravis with thymoma. Pediatr Neurol, 46(5), 329\u2013331. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2012.02.025.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"9847_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11910-010-0169-4","volume":"11","author":"EM Wells","year":"2011","unstructured":"Wells, E. M., & Dalmau, J. (2011). Paraneoplastic neurologic disorders in children. Curr Neurol Neuroscie Rep, 11(2), 187\u2013194. https:\/\/doi.org\/10.1007\/s11910-010-0169-4.","journal-title":"Curr Neurol Neuroscie Rep"},{"issue":"4","key":"9847_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau, J., & Rosenfeld, M. R. (2008). Paraneoplastic syndromes of the CNS. Lancet Neurol, 7(4), 327\u2013340. https:\/\/doi.org\/10.1016\/S1474-4422(08)70060-7.","journal-title":"Lancet Neurol"},{"issue":"8","key":"9847_CR15","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus, F., Delattre, J. Y., Antoine, J. C., Dalmau, J., Giometto, B., Grisold, W., Honnorat, J., Smitt, P. S., Vedeler Ch, Verschuuren, J. J., Vincent, A., & Voltz, R. (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 75(8), 1135\u20131140. https:\/\/doi.org\/10.1136\/jnnp.2003.034447.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9847_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.22941","volume":"25","author":"MR Pranzatelli","year":"2010","unstructured":"Pranzatelli, M. R., Tate, E. D., Swan, J. A., Travelstead, A. L., Colliver, J. A., Verhulst, S. J., Crosley, C. J., Graf, W. D., Joseph, S. A., Kelfer, H. M., & Raju, G. P. (2010). B cell depletion therapy for new-onset opsoclonus-myoclonus. Mov Disord, 25(2), 238\u2013242. https:\/\/doi.org\/10.1002\/mds.22941.","journal-title":"Mov Disord"},{"issue":"1","key":"9847_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","volume":"253","author":"S Shams\u2019ili","year":"2006","unstructured":"Shams\u2019ili, S., de Beukelaar, J., Gratama, J. W., Hooijkaas, H., van den Bent, M., van\u2019t Veer, M., & Sillevis Smitt, P. (2006). An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol, 253(1), 16\u201320. https:\/\/doi.org\/10.1007\/s00415-005-0882-0.","journal-title":"J Neurol"},{"issue":"24","key":"9847_CR18","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1212\/WNL.0b013e318296e9c3","volume":"80","author":"J Honnorat","year":"2013","unstructured":"Honnorat, J., Didelot, A., Karantoni, E., Ville, D., Ducray, F., Lambert, L., Deiva, K., Garcia, M., Pichit, P., Cavillon, G., Rogemond, V., DeLattre, J., & Tardieu, M. (2013). Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer. Neurology, 80(24), 2226\u20132232. https:\/\/doi.org\/10.1212\/WNL.0b013e318296e9c3.","journal-title":"Neurology"},{"issue":"6","key":"9847_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/MOP.0b013e3283402d2f","volume":"22","author":"N Florance-Ryan","year":"2010","unstructured":"Florance-Ryan, N., & Dalmau, J. (2010). Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents. Curr Opin Pediatr, 22(6), 739\u2013744. https:\/\/doi.org\/10.1097\/MOP.0b013e3283402d2f.","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"9847_CR20","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/0883073809343319","volume":"25","author":"A Lebas","year":"2010","unstructured":"Lebas, A., Husson, B., Didelot, A., Honnorat, J., & Tardieu, M. (2010). Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol, 25(6), 742\u2013745. https:\/\/doi.org\/10.1177\/0883073809343319.","journal-title":"J Child Neurol"},{"issue":"2","key":"9847_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/adc.2010.183897","volume":"96","author":"E Haberlandt","year":"2011","unstructured":"Haberlandt, E., Bast, T., Ebner, A., Holthausen, H., Kluger, G., Kravljanac, R., Kr\u00f6ll-Seger, J., Kurlemann, G., Makowski, C., Rostasy, K., Tuschen-Hofst\u00e4tter, E., Weber, G., Vincent, A., & Bien, C. G. (2011). Limbic encephalitis in children and adolescents. Arch Dis Child, 96(2), 186\u2013191. https:\/\/doi.org\/10.1136\/adc.2010.183897.","journal-title":"Arch Dis Child"},{"key":"9847_CR22","doi-asserted-by":"publisher","unstructured":"Nosadini M, Toldo I, Tascini B, Bien CG, Parmeggiani L, De Gaspari P, \u2026 Sartori S (2019). LGI1 and CASPR2 autoimmunity in children: systematic literature review and report of a young girl with Morvan syndrome. J Neuroimmunol, 335, 577008. doi:https:\/\/doi.org\/10.1016\/J.JNEUROIM.2019.577008.","DOI":"10.1016\/J.JNEUROIM.2019.577008"},{"issue":"4","key":"9847_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0000000000004861","volume":"90","author":"M Nikolaus","year":"2018","unstructured":"Nikolaus, M., Jackowski-Dohrmann, S., Pr\u00fcss, H., Schuelke, M., & Knierim, E. (2018). Morvan syndrome associated with CASPR2 and LGI1 antibodies in a child. Neurology, 90(4), 183\u2013185. https:\/\/doi.org\/10.1212\/WNL.0000000000004861.","journal-title":"Neurology"},{"issue":"5","key":"9847_CR24","doi-asserted-by":"publisher","first-page":"e1348","DOI":"10.1542\/peds.2011-2690","volume":"129","author":"NM Allen","year":"2012","unstructured":"Allen, N. M., McKeon, A., O\u2019Rourke, D. J., O\u2019Meara, A., & King, M. D. (2012). Excessive blinking and ataxia in a child with occult neuroblastoma and voltage-gated potassium channel antibodies. Pediatrics, 129(5), e1348\u2013e1352. https:\/\/doi.org\/10.1542\/peds.2011-2690.","journal-title":"Pediatrics"},{"key":"9847_CR25","first-page":"1","volume":"12","author":"MR Rosenfeld","year":"2018","unstructured":"Rosenfeld, M. R. (2018). Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia. Up To Date, 12, 1\u201312.","journal-title":"Up To Date"},{"issue":"6","key":"9847_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/mus.23502","volume":"46","author":"L Sharp","year":"2012","unstructured":"Sharp, L., & Vernino, S. (2012). Paraneoplastic neuromuscular disorders. Muscle Nerve, 46(6), 839\u2013840. https:\/\/doi.org\/10.1002\/mus.23502.","journal-title":"Muscle Nerve"},{"issue":"6","key":"9847_CR27","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1212\/WNL.0000000000002945","volume":"87","author":"A Amini","year":"2016","unstructured":"Amini, A., Lang, B., Heaney, D., & Irani, S. R. (2016). Multiple sequential antibody-associated syndromes with a recurrent mutated neuroblastoma. Neurology, 87(6), 634\u2013636. https:\/\/doi.org\/10.1212\/WNL.0000000000002945.","journal-title":"Neurology"},{"key":"9847_CR28","doi-asserted-by":"publisher","unstructured":"Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, \u2026 Honnorat J (2004). FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain, 127(10), 2331\u20132338. doi:https:\/\/doi.org\/10.1093\/brain\/awh247.","DOI":"10.1093\/brain\/awh247"},{"issue":"2","key":"9847_CR29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/01.WNL.0000129983.06983.4E","volume":"63","author":"R Linke","year":"2004","unstructured":"Linke, R., Schroeder, M., Helmberger, T., & Voltz, R. (2004). Antibody-positive paraneoplastic neurologic syndromes: Value of CT and PET for tumor diagnosis. Neurology, 63(2), 282\u2013286. https:\/\/doi.org\/10.1212\/01.WNL.0000129983.06983.4E.","journal-title":"Neurology"},{"key":"9847_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jneuroim.2008.05.033","volume":"201","author":"F Blaes","year":"2008","unstructured":"Blaes, F., Pike, M. G., & Lang, B. (2008). Autoantibodies in childhood opsoclonus-myoclonus syndrome. J Neuroimmunol, 201, 221\u2013226. https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.033.","journal-title":"J Neuroimmunol"},{"issue":"11","key":"9847_CR31","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s00467-005-2004-8","volume":"20","author":"DG van Vuurden","year":"2005","unstructured":"van Vuurden, D. G., Pl\u00f6tz, F. B., de Jong, M., Bokenkamp, A., & van Wijk, J. A. E. (2005). Therapeutic total plasma exchange in a child with neuroblastoma-related anti-Hu syndrome. Pediatr Nephrol, 20(11), 1655\u20131656. https:\/\/doi.org\/10.1007\/s00467-005-2004-8.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"9847_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00415-002-0706-4","volume":"249","author":"P Sillevis Smitt","year":"2002","unstructured":"Sillevis Smitt, P., Grefkens, J., De Leeuw, B., Van Den Bent, M., Van Putten, W., Hooijkaas, H., & Vecht, C. (2002). Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis\/sensory neuronopathy. J Neurol, 249(6), 745\u2013753. https:\/\/doi.org\/10.1007\/s00415-002-0706-4.","journal-title":"J Neurol"},{"key":"9847_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jocn.2018.10.099","volume":"61","author":"C Chong","year":"2019","unstructured":"Chong, C., Soon, D. T. L., & Yeo, L. L. L. (2019). Opsoclonus - myoclonus syndrome. J Clin Neurosci, 61, 254\u2013255. https:\/\/doi.org\/10.1016\/j.jocn.2018.10.099.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"9847_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/1043454204272560","volume":"22","author":"ED Tate","year":"2005","unstructured":"Tate, E. D., Allison, T. J., Pranzatelli, M. R., & Verhulst, S. J. (2005). Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs, 22(1), 8\u201319. https:\/\/doi.org\/10.1177\/1043454204272560.","journal-title":"J Pediatr Oncol Nurs"},{"issue":"3","key":"9847_CR35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/pbc.23131","volume":"58","author":"A Morales La Madrid","year":"2012","unstructured":"Morales La Madrid, A., Rubin, C. M., Kohrman, M., Pytel, P., & Cohn, S. L. (2012). Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma. Pediatr Blood Cancer, 58(3), 472\u2013474. https:\/\/doi.org\/10.1002\/pbc.23131.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"9847_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0887-8994(94)90127-9","volume":"10","author":"PG Fisher","year":"1994","unstructured":"Fisher, P. G., Wechsler, D. S., & Singer, H. S. (1994). Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome. Pediatr Neurol, 10(4), 309\u2013312. https:\/\/doi.org\/10.1016\/0887-8994(94)90127-9.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"9847_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0887-8994(92)90060-c","volume":"8","author":"AA Wilfong","year":"1992","unstructured":"Wilfong, A. A., Parke, J. T., & McCrary, J. A. (1992). Opsoclonus-myoclonus with Beckwith-Wiedemann syndrome and hepatoblastoma. Pediatr Neurol, 8(1), 77\u201379. https:\/\/doi.org\/10.1016\/0887-8994(92)90060-c.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"9847_CR38","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00431-002-0934-8","volume":"161","author":"JF Swart","year":"2002","unstructured":"Swart, J. F., De Kraker, J., & Van der Lely, N. (2002). Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome. Eur J Pediatr, 161(5), 255\u2013258. https:\/\/doi.org\/10.1007\/s00431-002-0934-8.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"9847_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/08830738060210070801","volume":"21","author":"CK McGarvey","year":"2006","unstructured":"McGarvey, C. K., Applegate, K., Lee, N. D., & Sokol, D. K. (2006). False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (ACTH). J Child Neurol, 21(7), 606\u2013610. https:\/\/doi.org\/10.1177\/08830738060210070801.","journal-title":"J Child Neurol"},{"key":"9847_CR40","doi-asserted-by":"publisher","unstructured":"Brunklaus, A., Pohl, K., Zuberi, S. M., & De Sousa, C. (2012). Investigating neuroblastoma in childhood opsoclonus-myoclonus syndrome. Arch Dis Child. https:\/\/doi.org\/10.1136\/adc.2010.204792.","DOI":"10.1136\/adc.2010.204792"},{"issue":"4","key":"9847_CR41","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/mds.25354","volume":"28","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo, J. F., Stocco, A., Muscal, E., & Jankovic, J. (2013). The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord, 28(4), 543\u2013547. https:\/\/doi.org\/10.1002\/mds.25354.","journal-title":"Mov Disord"},{"issue":"12","key":"9847_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/mds.25999","volume":"29","author":"SS Mohammad","year":"2014","unstructured":"Mohammad, S. S., Fung, V. S. C., Grattan-Smith, P., Gill, D., Pillai, S., Ramanathan, S., et al. (2014). Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord, 29(12), 1539\u20131542. https:\/\/doi.org\/10.1002\/mds.25999.","journal-title":"Mov Disord"},{"issue":"3","key":"9847_CR43","doi-asserted-by":"publisher","first-page":"e20160901","DOI":"10.1542\/peds.2016-0901","volume":"138","author":"AK Yeshokumar","year":"2016","unstructured":"Yeshokumar, A. K., Sun, L. R., Klein, J. L., Baranano, K. W., & Pardo, C. A. (2016). Gait disturbance as the presenting symptom in young children with anti-NMDA receptor encephalitis. Pediatrics, 138(3), e20160901. https:\/\/doi.org\/10.1542\/peds.2016-0901.","journal-title":"Pediatrics"},{"issue":"1","key":"9847_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ana.21074","volume":"61","author":"RB Darnell","year":"2007","unstructured":"Darnell, R. B. (2007). NMDA receptor as a target in paraneoplastic encephalitis. Ann Neurol, 61(1), 3\u20134. https:\/\/doi.org\/10.1002\/ana.21074.","journal-title":"Ann Neurol"},{"issue":"1","key":"9847_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau, J., T\u00fcz\u00fcn, E., Wu, H., & Masjuan, J. (2007). Paraneoplastic anti\u2013N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol, 61(1), 25\u201336.","journal-title":"Ann Neurol"},{"issue":"12","key":"9847_CR46","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008). Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol, 7(12), 1091\u20131098. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2.","journal-title":"Lancet Neurol"},{"issue":"4","key":"9847_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejpn.2017.03.005","volume":"21","author":"M Kunstreich","year":"2017","unstructured":"Kunstreich, M., Kreth, J. H., Oommen, P. T., Schaper, J., Karenfort, M., Aktas, O., Tibussek, D., Distelmaier, F., Borkhardt, A., & Kuhlen, M. (2017). Paraneoplastic limbic encephalitis with SOX1 and PCA2 antibodies and relapsing neurological symptoms in an adolescent with Hodgkin lymphoma. Eur J Paediatr Neurol, 21(4), 661\u2013665. https:\/\/doi.org\/10.1016\/j.ejpn.2017.03.005.","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"9847_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.ejpn.2016.08.013","volume":"21","author":"DWS Chan","year":"2017","unstructured":"Chan, D. W. S., Thomas, T., Lim, M., Ling, S., Woodhall, M., & Vincent, A. (2017). Focal status epilepticus and progressive dyskinesia: a novel phenotype for glycine receptor antibody-mediated neurological disease in children. Eur J Paediatr Neurol, 21(2), 414\u2013417. https:\/\/doi.org\/10.1016\/j.ejpn.2016.08.013.","journal-title":"Eur J Paediatr Neurol"},{"issue":"22","key":"9847_CR49","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola, M., Sabater, L., Planagum\u00e0, J., Mart\u00ednez-Hernandez, E., Armangu\u00e9, T., Pr\u00fcss, H., Iizuka, T., Capar\u00f3 Oblitas, R. L., Antoine, J. C., Li, R., Heaney, N., Tubridy, N., Munteis Olivas, E., Rosenfeld, M. R., Graus, F., & Dalmau, J. (2018). Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology, 90(22), e1964\u2013e1972. https:\/\/doi.org\/10.1212\/WNL.0000000000005614.","journal-title":"Neurology"},{"key":"9847_CR50","doi-asserted-by":"publisher","unstructured":"Rudock R, Helis J, & Mar SS (2017). Anti-glutamic acid decarboxylase limbic encephalitis. In Pediatric demyelinating diseases of the central nervous system and their mimics (pp. 67\u201373). Springer International Publishing. doi:https:\/\/doi.org\/10.1007\/978-3-319-61407-6_9.","DOI":"10.1007\/978-3-319-61407-6_9"},{"issue":"2","key":"9847_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas, N., Titulaer, M. J., Torrents, A., Aguilar, E., McCracken, L., Leypoldt, F., Gleichman, A. J., Balice-Gordon, R., Rosenfeld, M. R., Lynch, D., Graus, F., & Dalmau, J. (2014). Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol, 13(2), 167\u2013177. https:\/\/doi.org\/10.1016\/S1474-4422(13)70282-5.","journal-title":"Lancet Neurol"},{"issue":"3","key":"9847_CR52","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s11940-011-0116-y","volume":"13","author":"MR Rosenfeld","year":"2011","unstructured":"Rosenfeld, M. R., & Dalmau, J. (2011). Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol, 13(3), 324\u2013332. https:\/\/doi.org\/10.1007\/s11940-011-0116-y.","journal-title":"Curr Treat Options Neurol"},{"issue":"3","key":"9847_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00381-016-3284-y","volume":"33","author":"S Gungor","year":"2017","unstructured":"Gungor, S., Kilic, B., Arslan, M., Ozgen, U., & Dalmau, J. (2017). Hodgkin\u2019s lymphoma associated with paraneoplastic cerebellar degeneration in children: a case report and review of the literature. Childs Nerv Syst, 33(3), 509\u2013512. https:\/\/doi.org\/10.1007\/s00381-016-3284-y.","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"9847_CR54","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.anl.2012.01.003","volume":"39","author":"T Nakamura","year":"2012","unstructured":"Nakamura, T., Morimoto, N., Goto, F., Shioda, Y., Hoshino, H., Kubota, M., & Taiji, H. (2012). Langerhans cell histiocytosis with disequilibrium. Auris Nasus Larynx, 39(6), 627\u2013630. https:\/\/doi.org\/10.1016\/j.anl.2012.01.003.","journal-title":"Auris Nasus Larynx"},{"issue":"2","key":"9847_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00043426-200003000-00015","volume":"22","author":"S Emir","year":"2000","unstructured":"Emir, S., Tezer Kutluk, M., G\u00f6\u011f\u00fc\u015f, S., & B\u00fcy\u00fckpamuk\u00e7u, M. (2000). Paraneoplastic cerebellar degeneration and horner syndrome: association of two uncommon findings in a child with hodgkin disease. Am J Pediatr Hematol\/Oncol, 22(2), 158\u2013161. https:\/\/doi.org\/10.1097\/00043426-200003000-00015.","journal-title":"Am J Pediatr Hematol\/Oncol"},{"issue":"2","key":"9847_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11940-012-0215-4","volume":"15","author":"JE Greenlee","year":"2013","unstructured":"Greenlee, J. E. (2013). Treatment of paraneoplastic cerebellar degeneration. Curr Treat Options Neurol, 15(2), 185\u2013200. https:\/\/doi.org\/10.1007\/s11940-012-0215-4.","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"9847_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/1097-0142(19840301)53:5<1115::aid-cncr2820530517>3.0.co;2-w","volume":"53","author":"VJ Ojeda","year":"1984","unstructured":"Ojeda, V. J., & Ojeda, V. J. (1984). Necrotizing myelopathy associated with malignancy. a clinicopathologic study of two cases and literature review. Cancer, 53(5), 1115\u20131123. https:\/\/doi.org\/10.1002\/1097-0142(19840301)53:5<1115::aid-cncr2820530517>3.0.co;2-w.","journal-title":"Cancer"},{"issue":"5","key":"9847_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/archneur.65.5.629","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock, S. J., & Lennon, V. A. (2008). Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol, 65(5), 629\u2013632. https:\/\/doi.org\/10.1001\/archneur.65.5.629.","journal-title":"Arch Neurol"},{"issue":"8","key":"9847_CR59","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1016\/j.jpedsurg.2009.04.023","volume":"44","author":"AS de Buys Roessingh","year":"2009","unstructured":"de Buys Roessingh, A. S., Loriot, M. H., Wiesenauer, C., & Lallier, M. (2009). Lambert-Eaton myasthenic syndrome revealing an abdominal neuroblastoma. J Pediatr Surg, 44(8), E5\u2013E7. https:\/\/doi.org\/10.1016\/j.jpedsurg.2009.04.023.","journal-title":"J Pediatr Surg"},{"key":"9847_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2018.05.011","volume":"85","author":"LR Sun","year":"2018","unstructured":"Sun, L. R., & Cooper, S. (2018). Neurological complications of the treatment of pediatric neoplastic disorders. Pediatr Neurol, 85, 33\u201342. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2018.05.011.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"9847_CR61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/J.BANDL.2013.01.001","volume":"127","author":"M K\u00fcper","year":"2013","unstructured":"K\u00fcper, M., & Timmann, D. (2013). Cerebellar mutism. Brain Lang, 127(3), 327\u2013333. https:\/\/doi.org\/10.1016\/J.BANDL.2013.01.001.","journal-title":"Brain Lang"},{"issue":"12","key":"9847_CR62","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1177\/0883073815620673","volume":"31","author":"EC Neil","year":"2016","unstructured":"Neil, E. C., Hanmantgad, S., & Khakoo, Y. (2016). Neurological complications of pediatric cancer. J Child Neurol, 31(12), 1412\u20131420. https:\/\/doi.org\/10.1177\/0883073815620673.","journal-title":"J Child Neurol"},{"key":"9847_CR63","doi-asserted-by":"publisher","unstructured":"Newton HB (2012). Neurological complications of chemotherapy to the central nervous system. In Handbook of clinical neurology (Vol. 105, pp. 903\u2013916). Elsevier B.V. doi:https:\/\/doi.org\/10.1016\/B978-0-444-53502-3.00031-8.","DOI":"10.1016\/B978-0-444-53502-3.00031-8"},{"issue":"6","key":"9847_CR64","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/ana.24951","volume":"81","author":"A Grisold","year":"2017","unstructured":"Staff, N. P, Grisold, A., Grisold, W., & Windebank, A. J. (2017). Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol, 81(6), 772\u2013781. https:\/\/doi.org\/10.1002\/ana.24951.","journal-title":"Ann Neurol"},{"issue":"10","key":"9847_CR65","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nrclinonc.2009.128","volume":"6","author":"D Schiff","year":"2009","unstructured":"Schiff, D., Wen, P. Y., & van den Bent, M. J. (2009). Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol, 6(10), 596\u2013603. https:\/\/doi.org\/10.1038\/nrclinonc.2009.128.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"9847_CR66","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1016\/S1470-2045(16)30571-X","volume":"17","author":"W Wick","year":"2016","unstructured":"Wick, W., Hertenstein, A., & Platten, M. (2016). Neurological sequelae of cancer immunotherapies and targeted therapies. Lancet Oncol, 17(12), e529\u2013e541. https:\/\/doi.org\/10.1016\/S1470-2045(16)30571-X.","journal-title":"Lancet Oncol"},{"key":"9847_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fped.2017.00105","volume":"5","author":"DM Cordelli","year":"2017","unstructured":"Cordelli, D. M., Masetti, R., Zama, D., Toni, F., Castelli, I., Ricci, E., Franzoni, E., & Pession, A. (2017). Central nervous system complications in children receiving chemotherapy or hematopoietic stem cell transplantation. Front Pediatr, 5, 105. https:\/\/doi.org\/10.3389\/fped.2017.00105.","journal-title":"Front Pediatr"},{"key":"9847_CR68","doi-asserted-by":"publisher","unstructured":"Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, Von Geldern G, Moskowitz CH, \u2026 Bennett CL (2014). Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project. Cancer, 120(16), 2464\u20132471. doi:https:\/\/doi.org\/10.1002\/cncr.28712.","DOI":"10.1002\/cncr.28712"},{"key":"9847_CR69","unstructured":"Toxicology and Environmental Health Information Program (TEHIP). (2019). TOXNET. National Library of Medicine. Retrieved November 26, 2019, from https:\/\/toxnet.nlm.nih.gov\/index.html Accessed 12\/2\/2019."},{"key":"9847_CR70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3233\/PIC-14100","volume":"3","author":"F Aspesberro","year":"2014","unstructured":"Aspesberro, F., Milewski, L. S., & Brogan, T. V. (2014). Acute central nervous system complications in pediatric hematopoietic stem cell patients. J Pediatr Intensive Care, 3, 169\u2013181. https:\/\/doi.org\/10.3233\/PIC-14100.","journal-title":"J Pediatr Intensive Care"},{"key":"9847_CR71","doi-asserted-by":"publisher","unstructured":"Tibussek D, Natesirinilkul R, Sun LR, Wasserman, B. A., Brandao LR, deVeber G, \u2026 deVeber G (2016). Severe cerebral vasospasm and childhood arterial ischemic stroke after intrathecal cytarabine. Pediatrics, 137(2), e20152143\u2013e20152143. doi:https:\/\/doi.org\/10.1542\/peds.2015-2143.","DOI":"10.1542\/peds.2015-2143"},{"issue":"10","key":"9847_CR72","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/14737140.2017.1364995","volume":"17","author":"S Sait","year":"2017","unstructured":"Sait, S., & Modak, S. (2017). Anti-GD2 immunotherapy for neuroblastoma. Expert Rev Anticancer Ther, 17(10), 889\u2013904. https:\/\/doi.org\/10.1080\/14737140.2017.1364995.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"9847_CR73","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/jbiol69","volume":"7","author":"R Han","year":"2008","unstructured":"Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pr\u00f6schel, M., & Noble, M. (2008). Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol, 7(4), 12. https:\/\/doi.org\/10.1186\/jbiol69.","journal-title":"J Biol"},{"issue":"2","key":"9847_CR74","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/bjh.14921","volume":"179","author":"K Ewins","year":"2017","unstructured":"Ewins, K., Malone, A., Phelan, E., Webb, D., McHugh, J. C., & Smith, O. (2017). Nelarabine-induced peripheral and central neurotoxicity: can sequential MRI brain imaging help to define its natural history? Br J Haematol, 179(2), 294\u2013297. https:\/\/doi.org\/10.1111\/bjh.14921.","journal-title":"Br J Haematol"},{"issue":"Suppl 15","key":"9847_CR75","first-page":"P2.2","volume":"92","author":"C Judge","year":"2019","unstructured":"Judge, C., Moheb, N., & Melinosky, C. (2019). Nilotinib-associated demyelinating disease. Neurology, 92(Suppl 15), P2.2\u2013P093.","journal-title":"Neurology"},{"key":"9847_CR76","doi-asserted-by":"publisher","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, \u2026 Widemann BC (2016). Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N Eng J Med, 375(26), 2550\u20132560. doi:https:\/\/doi.org\/10.1056\/NEJMoa1605943.","DOI":"10.1056\/NEJMoa1605943"},{"issue":"4","key":"9847_CR77","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","volume":"152","author":"RF Grace","year":"2011","unstructured":"Grace, R. F., Dahlberg, S. E., Neuberg, D., Sallan, S. E., Connors, J. M., Neufeld, E. J., Deangelo, D. J., & Silverman, L. B. (2011). The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol, 152(4), 452\u2013459. https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08524.x.","journal-title":"Br J Haematol"},{"key":"9847_CR78","doi-asserted-by":"publisher","unstructured":"Mitchell LG, Andrew M, Abshire T, Halton J, Anderson R, Cherrick I, \u2026 Way C (2003). A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the Prophylactic antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) study. Cancer, 97(2), 508\u2013516. doi:https:\/\/doi.org\/10.1002\/cncr.11042.","DOI":"10.1002\/cncr.11042"},{"key":"9847_CR79","doi-asserted-by":"publisher","unstructured":"Caruso, V., Iacoviello, L., Di Castelnuovo, A., Storti, S., Mariani, G., De Gaetano, G., & Donati, M. B. (2006). Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood.\nhttps:\/\/doi.org\/10.1182\/blood-2006-04-015511.","DOI":"10.1182\/blood-2006-04-015511"},{"key":"9847_CR80","doi-asserted-by":"publisher","unstructured":"Greiner J, Schrappe M, Claviez A, Zimmermann M, Niemeyer C, Kolb R, \u2026 M\u00f6ricke A (2019). THROMBOTECT \u2013 a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica, 104(4), 756\u2013765. doi:https:\/\/doi.org\/10.3324\/haematol.2018.194175.","DOI":"10.3324\/haematol.2018.194175"},{"issue":"7","key":"9847_CR81","doi-asserted-by":"publisher","first-page":"e450","DOI":"10.1097\/MPH.0000000000001127","volume":"40","author":"P Malhotra","year":"2018","unstructured":"Malhotra, P., Jain, S., & Kapoor, G. (2018). Symptomatic cerebral sinovenous thrombosis associated with l-asparaginase in children with acute lymphoblastic leukemia: a single institution experience over 17\u00a0years. J Pediatr Hematol Oncol, 40(7), e450\u2013e453. https:\/\/doi.org\/10.1097\/MPH.0000000000001127.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"Suppl 2","key":"9847_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000073352","volume":"65","author":"P Nicolao","year":"2003","unstructured":"Nicolao, P., & Giometto, B. (2003). Neurological toxicity of ifosfamide. Oncology, 65(Suppl 2), 11\u201316. https:\/\/doi.org\/10.1159\/000073352.","journal-title":"Oncology"},{"issue":"3","key":"9847_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1177\/1550059413500777","volume":"45","author":"D Taupin","year":"2014","unstructured":"Taupin, D., Racela, R., & Friedman, D. (2014). Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature. Clin EEG Neurosci, 45(3), 222\u2013225. https:\/\/doi.org\/10.1177\/1550059413500777.","journal-title":"Clin EEG Neurosci"},{"issue":"9","key":"9847_CR84","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1200\/JCO.2013.53.0808","volume":"32","author":"D Bhojwani","year":"2014","unstructured":"Bhojwani, D., Sabin, N. D., Pei, D., Yang, J. J., Khan, R. B., Panetta, J. C., Krull, K. R., Inaba, H., Rubnitz, J. E., Metzger, M. L., Howard, S. C., Ribeiro, R. C., Cheng, C., Reddick, W. E., Jeha, S., Sandlund, J. T., Evans, W. E., Pui, C. H., & Relling, M. V. (2014). Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol, 32(9), 949\u2013959. https:\/\/doi.org\/10.1200\/JCO.2013.53.0808.","journal-title":"J Clin Oncol"},{"issue":"1","key":"9847_CR85","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/annonc\/mdm466","volume":"19","author":"H Inaba","year":"2008","unstructured":"Inaba, H., Khan, R. B., Laningham, F. H., Crews, K. R., Pui, C. H., & Daw, N. C. (2008). Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol, 19(1), 178\u2013184. https:\/\/doi.org\/10.1093\/annonc\/mdm466.","journal-title":"Ann Oncol"},{"issue":"10","key":"9847_CR86","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S2352-3026(16)30110-7","volume":"3","author":"YT Cheung","year":"2016","unstructured":"Cheung, Y. T., Sabin, N. D., Reddick, W. E., Bhojwani, D., Liu, W., Brinkman, T. M., Glass, J. O., Hwang, S. N., Srivastava, D., Pui, C. H., Robison, L. L., Hudson, M. M., & Krull, K. R. (2016). Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis. Lancet Haematol, 3(10), 456\u2013466. https:\/\/doi.org\/10.1016\/S2352-3026(16)30110-7.","journal-title":"Lancet Haematol"},{"issue":"2","key":"9847_CR87","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S0887-8994(99)00040-5","volume":"21","author":"S Koh","year":"1999","unstructured":"Koh, S., Nelson, M. D., Kovanlikaya, A., & Chen, L. S. (1999). Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment. Pediatr Neurol, 21(2), 576\u2013578. https:\/\/doi.org\/10.1016\/S0887-8994(99)00040-5.","journal-title":"Pediatr Neurol"},{"issue":"12","key":"9847_CR88","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1136\/jnnp.2007.121806","volume":"78","author":"MR Junna","year":"2007","unstructured":"Junna, M. R., & Rabinstein, A. A. (2007). Tacrolimus induced leukoencephalopathy presenting with status epilepticus and prolonged coma. J Neurol Neurosurg Psychiatry, 78(12), 1410\u20131411. https:\/\/doi.org\/10.1136\/jnnp.2007.121806.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"9847_CR89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(06)70679-2","volume":"6","author":"JC Antoine","year":"2007","unstructured":"Antoine, J. C., & Camdessanch\u00e9, J. P. (2007). Peripheral nervous system involvement in patients with cancer. Lancet Neurol, 6(1), 75\u201386. https:\/\/doi.org\/10.1016\/S1474-4422(06)70679-2.","journal-title":"Lancet Neurol"},{"issue":"3","key":"9847_CR90","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0883073815589758","volume":"31","author":"J-H Tang","year":"2016","unstructured":"Tang, J.-H., Tian, J.-M., Sheng, M., Hu, S.-Y., Li, Y., Zhang, L.-Y., Gu, Q., & Wang, Q. (2016). Study of posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia after induction chemotherapy. J Child Neurol, 31(3), 279\u2013284. https:\/\/doi.org\/10.1177\/0883073815589758.","journal-title":"J Child Neurol"},{"key":"9847_CR91","doi-asserted-by":"publisher","first-page":"29","DOI":"10.20517\/2347-8659.2018.35","volume":"5","author":"DB Landi","year":"2018","unstructured":"Landi, D. B., Thompson, E. M., & Ashley, D. M. (2018). Immunotherapy for pediatric brain tumors. Neuroimmunol Neuroinflamm, 5, 29. https:\/\/doi.org\/10.20517\/2347-8659.2018.35.","journal-title":"Neuroimmunol Neuroinflamm"},{"issue":"4","key":"9847_CR92","doi-asserted-by":"publisher","first-page":"370","DOI":"10.31486\/toj.18.0055","volume":"18","author":"TF Kabir","year":"2018","unstructured":"Kabir, T. F., Chauhan, A., Anthony, L., & Hildebrandt, G. C. (2018). Immune checkpoint inhibitors in pediatric solid tumors: status in 2018. Ochsner J, 18(4), 370\u2013376. https:\/\/doi.org\/10.31486\/toj.18.0055.","journal-title":"Ochsner J"},{"key":"9847_CR93","doi-asserted-by":"publisher","unstructured":"AlHarbi M, Mobark NA, AlMubarak L, Aljelaify R, AlSaeed M, Almutairi A, \u2026 Abedalthagafi M (2018). Durable response to nivolumab in a pediatric patient with refractory glioblastoma and constitutional biallelic mismatch repair deficiency Saudi human genome project View project medulloblastoma View project, 23(12), 1401\u20131406. doi:https:\/\/doi.org\/10.1634\/theoncologist.2018-0163.","DOI":"10.1634\/theoncologist.2018-0163"},{"key":"9847_CR94","doi-asserted-by":"publisher","unstructured":"Gorsi H, Malicki DM, Barsan, V, Tumblin M, Yeh-Nayre L, Milburn M, \u2026 Crawford JR (2019). Nivolumab in the treatment of recurrent or refractory pediatric brain tumors: a single institutional experience. J Pediatr Hematol\/Oncol, 41(4), e235\u2013241. doi:https:\/\/doi.org\/10.1097\/MPH.0000000000001339.","DOI":"10.1097\/MPH.0000000000001339"},{"issue":"8","key":"9847_CR95","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.it.2019.05.009","volume":"40","author":"SS Wang","year":"2019","unstructured":"Wang, S. S., Bandopadhayay, P., & Jenkins, M. R. (2019). Towards immunotherapy for pediatric brain tumors. Trends Immunol, 40(8), 748\u2013761. https:\/\/doi.org\/10.1016\/j.it.2019.05.009.","journal-title":"Trends Immunol"},{"key":"9847_CR96","doi-asserted-by":"publisher","unstructured":"Williams TJ, Benavides DR, Patrice, K A, Dalmau JO, De \u00c1vila AL R, Le DT, \u2026 Mowry EM (2016). Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol, 73(8), 928\u2013933. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2016.1399.","DOI":"10.1001\/jamaneurol.2016.1399"},{"issue":"9","key":"9847_CR97","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.mayocp.2019.02.003","volume":"94","author":"A Zekeridou","year":"2019","unstructured":"Zekeridou, A., & Lennon, V. A. (2019). Neurologic autoimmunity in the era of checkpoint inhibitor cancer immunotherapy. Mayo Clin Proc, 94(9), 1865\u20131878. https:\/\/doi.org\/10.1016\/j.mayocp.2019.02.003.","journal-title":"Mayo Clin Proc"},{"key":"9847_CR98","doi-asserted-by":"publisher","first-page":"175628641879986","DOI":"10.1177\/1756286418799864","volume":"11","author":"MC Dalakas","year":"2018","unstructured":"Dalakas, M. C. (2018). Neurological complications of immune checkpoint inhibitors: what happens when you \u2018take the brakes off\u2019 the immune system. Ther Adv Neurol Disord, 11, 1756286418799864. https:\/\/doi.org\/10.1177\/1756286418799864.","journal-title":"Ther Adv Neurol Disord"},{"key":"9847_CR99","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","volume":"34","author":"JN Brudno","year":"2019","unstructured":"Brudno, J. N., & Kochenderfer, J. N. (2019). Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev, 34, 45\u201355. https:\/\/doi.org\/10.1016\/j.blre.2018.11.002.","journal-title":"Blood Rev"},{"key":"9847_CR100","doi-asserted-by":"publisher","unstructured":"Gust, J., Hay KA, Hanafi L A, Li D, Myerson D, Gonzalez-Cuyar LF, \u2026 Turtle CJ (2017). Endothelial activation and blood\u2013brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells. Cancer Discov doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0698.","DOI":"10.1158\/2159-8290.CD-17-0698"},{"key":"9847_CR101","doi-asserted-by":"publisher","unstructured":"Hay, K. A. (2018). Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.15644.","DOI":"10.1111\/bjh.15644"},{"key":"9847_CR102","doi-asserted-by":"publisher","unstructured":"Santomasso BD, Park JH, Salloum D, Riviere, I., Flynn J, Mead E, \u2026 Brentjens RJ (2018). Clinical and biological correlates of neurotoxicity associated with car t-cell therapy in patients with B-cell acute lymphoblastic leukemia. Cancer Discov. doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1319.","DOI":"10.1158\/2159-8290.CD-17-1319"},{"key":"9847_CR103","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00415-019-09444-4","volume":"266","author":"MD Willis","year":"2019","unstructured":"Willis, M. D., & Robertson, N. P. (2019). Neurotoxicity of novel cancer immunotherapies. J Neurol, 266, 2087\u20132089. https:\/\/doi.org\/10.1007\/s00415-019-09444-4.","journal-title":"J Neurol"},{"issue":"12","key":"9847_CR104","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s40263-018-0582-9","volume":"32","author":"J Gust","year":"2018","unstructured":"Gust, J., Taraseviciute, A., & Turtle, C. J. (2018). Neurotoxicity associated with CD19-targeted CAR-T cell therapies. CNS Drugs, 32(12), 1091\u20131101. https:\/\/doi.org\/10.1007\/s40263-018-0582-9.","journal-title":"CNS Drugs"},{"key":"9847_CR105","doi-asserted-by":"publisher","unstructured":"Le RQ, Li L, Yuan W, Shord SS, Nie L, Habtemariam BA, \u2026 Pazdur R (2018). FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome. The Oncologist, 23(8), 943\u2013947. doi:https:\/\/doi.org\/10.1634\/theoncologist.2018-0028.","DOI":"10.1634\/theoncologist.2018-0028"},{"issue":"6","key":"9847_CR106","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000446075","volume":"51","author":"MR Reynolds","year":"2016","unstructured":"Reynolds, M. R., Haydon, D. H., Caird, J., & Leonard, J. R. (2016). Radiation-induced moyamoya syndrome after proton beam therapy in the pediatric patient: a case series. Pediatr Neurosurg, 51(6), 297\u2013301. https:\/\/doi.org\/10.1159\/000446075.","journal-title":"Pediatr Neurosurg"},{"issue":"8254","key":"9847_CR107","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0140-6736(81)91216-2","volume":"2","author":"AT Meadows","year":"1981","unstructured":"Meadows, A. T., Massari, D. J., Fergusson, J., Gordon, J., Littman, P., & Moss, K. (1981). Declines in IQ scores and cognitive dysfunctions in children with acute lymphocytic leukaemia treated with cranial irradiation. Lancet, 2(8254), 1015\u20131018. https:\/\/doi.org\/10.1016\/S0140-6736(81)91216-2.","journal-title":"Lancet"},{"issue":"7","key":"9847_CR108","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s003819900125","volume":"16","author":"A Amirjamshidi","year":"2000","unstructured":"Amirjamshidi, A., & Abbassioun, K. (2000). Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Childs Nerv Syst, 16(7), 390\u2013397. https:\/\/doi.org\/10.1007\/s003819900125.","journal-title":"Childs Nerv Syst"},{"issue":"7","key":"9847_CR109","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/0883073814544364","volume":"30","author":"E Gastelum","year":"2015","unstructured":"Gastelum, E., Sear, K., Hills, N., Roddy, E., Randazzo, D., Chettout, N., Hess, C., Cotter, J., Haas-Kogan, D. A., Fullerton, H., & Mueller, S. (2015). Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients. J Child Neurol, 30(7), 842\u2013849. https:\/\/doi.org\/10.1177\/0883073814544364.","journal-title":"J Child Neurol"},{"issue":"5","key":"9847_CR110","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00066-008-1817-3","volume":"184","author":"V Strenger","year":"2008","unstructured":"Strenger, V., Sovinz, P., Lackner, H., Dornbusch, H. J., Lingitz, H., Eder, H. G., Moser, A., & Urban, C. (2008). Intracerebral cavernous hemangioma after cranial irradiation in childhood: incidence and risk factors. Strahlenther Onkol, 184(5), 276\u2013280. https:\/\/doi.org\/10.1007\/s00066-008-1817-3.","journal-title":"Strahlenther Onkol"},{"issue":"Suppl 2","key":"9847_CR111","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3171\/ped.2006.104.2.6","volume":"104","author":"SM Lew","year":"2006","unstructured":"Lew, S. M., Morgan, J. N., Psaty, E., Lefton, D. R., Allen, J. C., & Abbott, R. (2006). Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg, 104(Suppl 2), 103\u2013107. https:\/\/doi.org\/10.3171\/ped.2006.104.2.6.","journal-title":"J Neurosurg"},{"issue":"2","key":"9847_CR112","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3171\/ped.2006.105.2.134","volume":"105","author":"DM Sciubba","year":"2006","unstructured":"Sciubba, D. M., Gallia, G. L., Recinos, P., Garonzik, I. M., & Clatterbuck, R. E. (2006). Intracranial aneurysm following radiation therapy during childhood for a brain tumor: case report and review of the literature. J Neurosurg, 105(2), 134\u2013139. https:\/\/doi.org\/10.3171\/ped.2006.105.2.134.","journal-title":"J Neurosurg"},{"issue":"1","key":"9847_CR113","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/epi.13963","volume":"59","author":"EP Fan","year":"2018","unstructured":"Fan, E. P., Heiber, G., Gerard, E. E., & Schuele, S. (2018). Stroke-like migraine attacks after radiation therapy: a misnomer? Epilepsia, 59(1), 259\u2013268. https:\/\/doi.org\/10.1111\/epi.13963.","journal-title":"Epilepsia"},{"key":"9847_CR114","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jocn.2017.05.013","volume":"43","author":"K Wai","year":"2017","unstructured":"Wai, K., Balabanski, A., Chia, N., & Kleinig, T. (2017). Reversible hemispheric hypoperfusion in two cases of SMART syndrome. J Clin Neurosci, 43, 146\u2013148. https:\/\/doi.org\/10.1016\/j.jocn.2017.05.013.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"9847_CR115","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/mus.25778","volume":"56","author":"MD Stubblefield","year":"2017","unstructured":"Stubblefield, M. D. (2017). Neuromuscular complications of radiation therapy. Muscle Nerve, 56(6), 1031\u20131040. https:\/\/doi.org\/10.1002\/mus.25778.","journal-title":"Muscle Nerve"},{"issue":"21","key":"9847_CR116","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djj411","volume":"98","author":"JP Neglia","year":"2006","unstructured":"Neglia, J. P., Robison, L. L., Stovall, M., Liu, Y., Packer, R. J., Hammond, S., Yasui, Y., Kasper, C. E., Mertens, A. C., Donaldson, S. S., Meadows, A. T., & Inskip, P. D. (2006). New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst, 98(21), 1528\u20131537. https:\/\/doi.org\/10.1093\/jnci\/djj411.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"9847_CR117","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1093\/annonc\/mdw155","volume":"27","author":"M Schmidt-Hieber","year":"2016","unstructured":"Schmidt-Hieber, M., Silling, G., Schalk, E., Heinz, W., Panse, J., Penack, O., Christopeit, M., Buchheidt, D., Meyding-Lamad\u00e9, U., H\u00e4hnel, S., Wolf, H. H., Ruhnke, M., Schwartz, S., & Maschmeyer, G. (2016). CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-guidelines of the infectious DiseasesWorking party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol, 27(7), 1207\u20131225. https:\/\/doi.org\/10.1093\/annonc\/mdw155.","journal-title":"Ann Oncol"},{"issue":"3","key":"9847_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13381","volume":"23","author":"M Schoettler","year":"2019","unstructured":"Schoettler, M., Duncan, C., & Lehmann, L. (2019). Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab. Pediatr Transplant, 23(3), e13381. https:\/\/doi.org\/10.1111\/petr.13381.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"9847_CR119","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00247-017-4023-6","volume":"48","author":"MJ Callahan","year":"2018","unstructured":"Callahan, M. J., MacDougall, R. D., Bixby, S. D., Voss, S. D., Robertson, R. L., & Cravero, J. P. (2018). Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. Pediatr Radiol, 48(1), 21\u201330. https:\/\/doi.org\/10.1007\/s00247-017-4023-6.","journal-title":"Pediatr Radiol"},{"issue":"8","key":"9847_CR120","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3174\/ajnr.A5724","volume":"39","author":"A Tekes","year":"2018","unstructured":"Tekes, A., Senglaub, S. S., Ahn, E. S., Huisman, T. A. G. M., & Jackson, E. M. (2018). Ultrafast brain MRI can be used for indications beyond shunted hydrocephalus in pediatric patients. Am J Neuroradiol, 39(8), 1515\u20131518. https:\/\/doi.org\/10.3174\/ajnr.A5724.","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"9847_CR121","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1001\/archneur.57.12.1727","volume":"57","author":"R Tuma","year":"2000","unstructured":"Tuma, R., & DeAngelis, L. M. (2000). Altered mental status in patients with cancer. Arch Neurol, 57(12), 1727\u20131731. https:\/\/doi.org\/10.1001\/archneur.57.12.1727.","journal-title":"Arch Neurol"},{"issue":"3","key":"9847_CR122","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eplepsyres.2005.03.007","volume":"64","author":"RB Khan","year":"2005","unstructured":"Khan, R. B., Hunt, D. L., Boop, F. A., Sanford, R. A., Merchant, T. E., Gajjar, A., & Kun, L. E. (2005). Seizures in children with primary brain tumors: Incidence and long-term outcome. Epilepsy Res, 64(3), 85\u201391. https:\/\/doi.org\/10.1016\/j.eplepsyres.2005.03.007.","journal-title":"Epilepsy Res"},{"issue":"2","key":"9847_CR123","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S1059-1311(03)00083-9","volume":"13","author":"K Ibrahim","year":"2004","unstructured":"Ibrahim, K., & Appleton, R. E. (2004). Seizures as the presenting symptom of brain tumours in children. Seizure, 13(2), 108\u2013112. https:\/\/doi.org\/10.1016\/S1059-1311(03)00083-9.","journal-title":"Seizure"},{"key":"9847_CR124","doi-asserted-by":"publisher","unstructured":"Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, \u2026 Cairncross JG (2000). Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the quality standards Subcommittee of the American Academy of neurology. Neurology, 54(10), 1886\u20131893. doi:https:\/\/doi.org\/10.1212\/WNL.54.10.1886.","DOI":"10.1212\/WNL.54.10.1886"},{"key":"9847_CR125","doi-asserted-by":"publisher","unstructured":"Hardesty, D. A., Sanborn, M. R., Parker, W. E., & Storm, P. B. (2011). Perioperative seizure incidence and risk factors in 223 pediatric brain tumor patients without prior seizures: clinical article. J Neurosurg Pediatr. https:\/\/doi.org\/10.3171\/2011.3.PEDS1120.","DOI":"10.3171\/2011.3.PEDS1120"},{"key":"9847_CR126","doi-asserted-by":"publisher","DOI":"10.1017\/9781108669399","volume-title":"The epilepsy prescriber\u2019s guide to antiepileptic drugs","author":"PN Patsalos","year":"2018","unstructured":"Patsalos, P. N., & St. Louis, E. K. (2018). The epilepsy prescriber\u2019s guide to antiepileptic drugs (3rd ed.). Cambridge: Cambridge University Press. https:\/\/doi.org\/10.1017\/9781108669399.","edition":"3"},{"issue":"1","key":"9847_CR127","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/bf00151245","volume":"10","author":"The Childhood Brain Tumor Consortium","year":"1991","unstructured":"The Childhood Brain Tumor Consortium. (1991). The epidemiology of headache among children with brain tumor. Headache in children with brain tumors. J Neuro-Oncol, 10(1), 31\u201346. https:\/\/doi.org\/10.1007\/bf00151245.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"9847_CR128","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11910-007-0005-7","volume":"7","author":"S Kirby","year":"2007","unstructured":"Kirby, S., & Purdy, R. A. (2007). Headache and brain tumors. Curr Neurol Neurosci Rep, 7(2), 110\u2013116. https:\/\/doi.org\/10.1007\/s11910-007-0005-7.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"9847_CR129","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/pm\/pnw218","volume":"18","author":"CJ Demaree","year":"2016","unstructured":"Demaree, C. J., Soliz, J. M., & Gebhardt, R. (2016). Cancer seeding risk from an epidural blood patch in patients with leukemia or lymphoma. Pain Med, 18(4), 218. https:\/\/doi.org\/10.1093\/pm\/pnw218.","journal-title":"Pain Med"},{"issue":"4","key":"9847_CR130","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/1043454214532026","volume":"31","author":"R Rusch","year":"2014","unstructured":"Rusch, R., Schulta, C., Hughes, L., & Withycombe, J. S. (2014). Evidence-based practice recommendations to prevent\/manage post-lumbar puncture headaches in pediatric patients receiving intrathecal chemotherapy. J Pediatr Oncol Nurs, 31(4), 230\u2013238. https:\/\/doi.org\/10.1177\/1043454214532026.","journal-title":"J Pediatr Oncol Nurs"},{"issue":"4","key":"9847_CR131","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/1043454207303884","volume":"24","author":"LC-Y Lee","year":"2007","unstructured":"Lee, L. C.-Y., Sennett, M., & Erickson, J. M. (2007). Prevention and management of post\u2013lumbar puncture headache in pediatric oncology patients. J Pediatr Oncol Nurs, 24(4), 200\u2013207. https:\/\/doi.org\/10.1177\/1043454207303884.","journal-title":"J Pediatr Oncol Nurs"},{"issue":"16","key":"9847_CR132","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1212\/WNL.0b013e31828cf81e","volume":"80","author":"SM Kranick","year":"2013","unstructured":"Kranick, S. M., Campen, C. J., Kasner, S. E., Kessler, S. K., Zimmerman, R. A., Lustig, R. A., Phillips, P. C., Beslow, L. A., Ichord, R., & Fisher, M. J. (2013). Headache as a risk factor for neurovascular events in pediatric brain tumor patients. Neurology, 80(16), 1452\u20131456. https:\/\/doi.org\/10.1212\/WNL.0b013e31828cf81e.","journal-title":"Neurology"},{"issue":"9","key":"9847_CR133","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1111\/j.1468-2982.2006.01184.x","volume":"26","author":"D Black","year":"2006","unstructured":"Black, D., Bartleson, J., Bell, M., & Lachance, D. (2006). SMART: stroke-like migraine attacks after radiation therapy. Cephalalgia, 26(9), 1137\u20131142. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01184.x.","journal-title":"Cephalalgia"},{"key":"9847_CR134","doi-asserted-by":"publisher","unstructured":"Sporns PB, Str\u00e4ter R, Minnerup, J, Wiendl H, Hanning U, Chapot R, \u2026 Kemmling A (2019). Feasibility, safety, and outcome of endovascular recanalization in childhood stroke: the Save ChildS Study. JAMA Neurol. doi:https:\/\/doi.org\/10.1001\/jamaneurol.2019.3403.","DOI":"10.1001\/jamaneurol.2019.3403"},{"issue":"6","key":"9847_CR135","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ana.25242","volume":"83","author":"S Bigi","year":"2018","unstructured":"Bigi, S., Dulcey, A., Gralla, J., Bernasconi, C., Melliger, A., Datta, A. N., Arnold, M., Kaesmacher, J., Fluss, J., Hackenberg, A., Maier, O., Weber, J., Poloni, C., Fischer, U., & Steinlin, M. (2018). Feasibility, safety, and outcome of recanalization treatment in childhood stroke. Ann Neurol, 83(6), 1125\u20131132. https:\/\/doi.org\/10.1002\/ana.25242.","journal-title":"Ann Neurol"},{"issue":"12","key":"9847_CR136","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1161\/STROKEAHA.119.025497","volume":"50","author":"C Amlie-Lefond","year":"2019","unstructured":"Amlie-Lefond, C., & Wainwright, M. S. (2019). Organizing for acute arterial ischemic stroke in children. Stroke, 50(12), 3662\u20133668. https:\/\/doi.org\/10.1161\/STROKEAHA.119.025497.","journal-title":"Stroke"},{"issue":"6","key":"9847_CR137","first-page":"545","volume":"42","author":"M Furuhata","year":"2014","unstructured":"Furuhata, M., Aihara, Y., Eguchi, S., Horiba, A., Tanaka, M., Komori, T., & Okada, Y. (2014). Pediatric medulloblastoma presenting as cerebellar hemorrhage: a case report. No shinkei geka. Neurol Surg, 42(6), 545\u2013551.","journal-title":"Neurol Surg"},{"issue":"4","key":"9847_CR138","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2015.10.PEDS1580","volume":"17","author":"MP Wilson","year":"2016","unstructured":"Wilson, M. P., Johnson, E. S., Hawkins, C., Atkins, K., Alshaya, W., & Pugh, J. A. (2016). Hemorrhagic presentations of cerebellar pilocytic astrocytomas in children resulting in death: report of 2 cases. J Neurosurg Pediatr, 17(4), 446\u2013452. https:\/\/doi.org\/10.3171\/2015.10.PEDS1580.","journal-title":"J Neurosurg Pediatr"},{"issue":"2","key":"9847_CR139","first-page":"194","volume":"76","author":"RJ Packer","year":"1985","unstructured":"Packer, R. J., Rorke, L. B., Lange, B. J., Siegel, K. R., & Evans, A. E. (1985). Cerebrovascular accidents in children with cancer. Pediatrics, 76(2), 194\u2013201.","journal-title":"Pediatrics"},{"issue":"1","key":"9847_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.mop.0000193270.09001.ea","volume":"18","author":"L Bajzar","year":"2006","unstructured":"Bajzar, L., Chan, A. K., Massicotte, M. P., & Mitchell, L. G. (2006). Thrombosis in children with malignancy. Curr Opin Pediatr, 18(1), 1\u20139. https:\/\/doi.org\/10.1097\/01.mop.0000193270.09001.ea.","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"9847_CR141","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/A:1006298201101","volume":"43","author":"U Herrlinger","year":"1999","unstructured":"Herrlinger, U., Schabet, M., Bitzer, M., Petersen, D., & Krauseneck, P. (1999). Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neuro-Oncol, 43(3), 219\u2013226. https:\/\/doi.org\/10.1023\/A:1006298201101.","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"9847_CR142","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1212\/wnl.57.3.393","volume":"57","author":"U B\u00fchring","year":"2001","unstructured":"B\u00fchring, U., Herrlinger, U., Krings, T., Thiex, R., Weller, M., & K\u00fcker, W. (2001). MRI features of primary central nervous system lymphomas at presentation. Neurology, 57(3), 393\u2013396. https:\/\/doi.org\/10.1212\/wnl.57.3.393.","journal-title":"Neurology"},{"issue":"12","key":"9847_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27415","volume":"65","author":"KL Bjornard","year":"2018","unstructured":"Bjornard, K. L., Leventaki, V., Nichols, K. E., Sandlund, J. T., Prockop, S., & Ehrhardt, M. J. (2018). Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis. Pediatr Blood Cancer, 65(12), e27415. https:\/\/doi.org\/10.1002\/pbc.27415.","journal-title":"Pediatr Blood Cancer"},{"key":"9847_CR144","doi-asserted-by":"publisher","unstructured":"Grisariu S, Avni B, Batchelor T T, Bent MJ van den, Bokstein F, Schiff, D, \u2026 Siegal T (2010). Neurolymphomatosis: an international primary CNS lymphoma collaborative group report. Blood, 115(24), 5005\u20135011. doi:https:\/\/doi.org\/10.1182\/BLOOD-2009-12-258210.","DOI":"10.1182\/BLOOD-2009-12-258210"},{"issue":"suppl 4","key":"9847_CR145","doi-asserted-by":"publisher","first-page":"v45","DOI":"10.1093\/neuonc\/nos203","volume":"14","author":"W Grisold","year":"2012","unstructured":"Grisold, W., Cavaletti, G., & Windebank, A. J. (2012). Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention. Neuro-Oncology, 14(suppl 4), v45\u2013v54. https:\/\/doi.org\/10.1093\/neuonc\/nos203.","journal-title":"Neuro-Oncology"},{"issue":"3","key":"9847_CR146","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/cncr.26337","volume":"118","author":"KK Ness","year":"2012","unstructured":"Ness, K. K., Hudson, M. M., Pui, C. H., Green, D. M., Krull, K. R., Huang, T. T., Robison, L. L., & Morris, E. B. (2012). Neuromuscular impairments in adult survivors of childhood acute lymphoblastic leukemia: associations with physical performance and chemotherapy doses. Cancer, 118(3), 828\u2013838. https:\/\/doi.org\/10.1002\/cncr.26337.","journal-title":"Cancer"},{"issue":"2","key":"9847_CR147","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00520-014-2408-8","volume":"23","author":"SH Chu","year":"2015","unstructured":"Chu, S. H., Lee, Y. J., Lee, E. S., Geng, Y., Wang, X. S., & Cleeland, C. S. (2015). Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: A systematic review. Support Care Cancer, 23(2), 513\u2013524. https:\/\/doi.org\/10.1007\/s00520-014-2408-8.","journal-title":"Support Care Cancer"},{"issue":"6","key":"9847_CR148","first-page":"571","volume":"21","author":"S Hou","year":"2018","unstructured":"Hou, S., Huh, B., Kim, H. K., Kim, K. H., & Abdi, S. (2018). Treatment of chemotherapy-induced peripheral neuropathy: systematic review and recommendations. Pain Physician, 21(6), 571\u2013592.","journal-title":"Pain Physician"}],"updated-by":[{"DOI":"10.1007\/s10555-020-09867-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T00:00:00Z","timestamp":1581465600000}}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09847-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-020-09847-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-020-09847-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T16:27:15Z","timestamp":1610468835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-020-09847-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9847"],"URL":"https:\/\/doi.org\/10.1007\/s10555-020-09847-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10555-020-09867-w","asserted-by":"object"}]},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"13 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have noticed a typographical error in the published article.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}